The role of miR-145 in stem cell characteristics of human laryngeal squamous cell carcinoma Hep-2 cells

The cancer stem-like cells (CSLCs) are tumorigenic cells promoting initiation, progression, and spread of the tumor. Accumulating evidences suggested the presence of CSLCs in distinct tumors including laryngeal squamous cell carcinoma (LSCC). MicroRNAs have been proposed as significant regulators of carcinogenesis, and several of them have been demonstrated to have direct roles in survival of CSLCs. In this study, we aimed to explore the role of miR-145, which is downregulated in LSCC, on cancer stem cell potency of laryngeal cancer cells. We initially showed the downregulation of miR-145 expression in tumor tissue samples and in CD133-enriched CSLCs. Quantitative reverse-transcription PCR (qRT-PCR) analysis of miR-145-transfected Hep-2 cells demonstrated the inhibitory role of miR-145 on stem cell markers like SOX2, OCT4, KLF4, and ABCG2. We, then, investigated the stem cell features of miR-145-overexpressing Hep-2 cells by sphere formation assay, single-cell cloning assay, and aldehyde dehydrogenase (ALDH) assay, which all demonstrated the inhibition of stem cell potency upon miR-145 overexpression. Further qRT-PCR analysis demonstrated altered expression of epithelial to mesenchymal transition markers in miR-145-overexpressing Hep-2 cells. In conclusion, we demonstrated the regulatory role of miR-145 in stem cell characteristics of Hep-2 cells. Based on these results, we propose that miR-145 might carry crucial roles in LSCC tumorigenesis, prognosis, metastasis, chemoresistance, and recurrence through regulating stem cell properties of tumor cells.

[1]  P. Russell,et al.  Radiotherapy in larynx squamous cell carcinoma is not associated with an increased diagnosis of second primary tumours. , 2009, Clinical oncology (Royal College of Radiologists (Great Britain)).

[2]  B. Vogelstein,et al.  A genetic model for colorectal tumorigenesis , 1990, Cell.

[3]  M. Lleonart,et al.  MicroRNAs and cancer stem cells: therapeutic approaches and future perspectives. , 2013, Cancer letters.

[4]  Jack J. Jiang,et al.  CD133, One of the Markers of Cancer Stem Cells in Hep‐2 Cell Line , 2007, The Laryngoscope.

[5]  J. Schalken,et al.  Stem cell characteristics in prostate cancer cell lines. , 2010, European urology.

[6]  J. Massagué,et al.  Beyond tumorigenesis: cancer stem cells in metastasis , 2007, Cell Research.

[7]  Y. Barrandon,et al.  Three clonal types of keratinocyte with different capacities for multiplication. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Hideo Baba,et al.  Epithelial–mesenchymal transition in cancer development and its clinical significance , 2010, Cancer science.

[9]  R. Gregory,et al.  MicroRNA gene regulatory pathways in the establishment and maintenance of ESC identity. , 2010, Cell stem cell.

[10]  Duan Ma,et al.  Comprehensive expression profiling of microRNAs in laryngeal squamous cell carcinoma , 2013, Head & neck.

[11]  D. Stolz,et al.  A stochastic model for cancer stem cell origin in metastatic colon cancer. , 2008, Cancer research.

[12]  W. Fitzgerald,et al.  Isolation and Clonal Analysis of Human Epidermal Keratinocyte Stem Cells in Long‐Term Culture , 2003, Stem cells.

[13]  Wenjun Guo,et al.  The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.

[14]  Daniel Birnbaum,et al.  ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. , 2007, Cell stem cell.

[15]  Lucila Ohno-Machado,et al.  Snail2 is an essential mediator of Twist1-induced epithelial mesenchymal transition and metastasis. , 2011, Cancer research.

[16]  A. Cittadini,et al.  Cancer stem cells in colorectal cancer from pathogenesis to therapy: controversies and perspectives. , 2014, World journal of gastroenterology.

[17]  Zuoren Yu,et al.  Cancer stem cells. , 2012, The international journal of biochemistry & cell biology.

[18]  M. B. Duz,et al.  The role of miRNAs in cancer: from pathogenesis to therapeutic implications. , 2014, Future oncology.

[19]  You-hong Cui,et al.  A novel approach to the identification and enrichment of cancer stem cells from a cultured human glioma cell line. , 2009, Cancer letters.

[20]  G. Pellegrini,et al.  Location and Clonal Analysis of Stem Cells and Their Differentiated Progeny in the Human Ocular Surface , 1999, The Journal of cell biology.

[21]  Jing Gong,et al.  MicroRNA145 targets BNIP3 and suppresses prostate cancer progression. , 2010, Cancer research.

[22]  E. van Rooij,et al.  Developing microRNA therapeutics. , 2012, Circulation research.

[23]  M. Nykter,et al.  MicroRNA expression profile of primary prostate cancer stem cells as a source of biomarkers and therapeutic targets. , 2015, European urology.

[24]  Mustafa Ozen,et al.  Role of miR‐145 in human laryngeal squamous cell carcinoma , 2016, Head & neck.

[25]  Cynthia Hawkins,et al.  Identification of a cancer stem cell in human brain tumors. , 2003, Cancer research.

[26]  Gerhard Christofori,et al.  EMT, the cytoskeleton, and cancer cell invasion , 2009, Cancer and Metastasis Reviews.

[27]  Juan Li,et al.  Emerging Role of MicroRNAs in Cancer and Cancer Stem Cells , 2014, Journal of cellular biochemistry.

[28]  X. Bian,et al.  [Isolation and identification of tumor stem-like cells from human glioma cell line U87 after treatment of vincristine]. , 2007, Ai zheng = Aizheng = Chinese journal of cancer.

[29]  M. Ozen,et al.  Alpha‐B‐crystallin expression in human laryngeal squamous cell carcinoma tissues , 2015, Head & neck.

[30]  R. Huang,et al.  Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.

[31]  G. Pan,et al.  MicroRNA-145 Regulates OCT4, SOX2, and KLF4 and Represses Pluripotency in Human Embryonic Stem Cells , 2009, Cell.

[32]  Jack J. Jiang,et al.  In vivo investigation of CD133 as a putative marker of cancer stem cells in Hep‐2 cell line , 2009, Head & neck.

[33]  S. Morrison,et al.  Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Xin Chen,et al.  PC3 human prostate carcinoma cell holoclones contain self-renewing tumor-initiating cells. , 2008, Cancer research.

[35]  B. Novitch,et al.  Vertebrate neurogenesis is counteracted by Sox1–3 activity , 2003, Nature Neuroscience.

[36]  M. Ozen,et al.  Characterization of stem-like cells directly isolated from freshly resected laryngeal squamous cell carcinoma specimens. , 2014, Current stem cell research & therapy.

[37]  Ali H. Brivanlou,et al.  Signaling Pathways in Cancer and Embryonic Stem Cells , 2007, Stem Cell Reviews.

[38]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[39]  X. Bian,et al.  Metastatic cancer stem cells: from the concept to therapeutics. , 2014, American journal of stem cells.